scholarly article | Q13442814 |
P356 | DOI | 10.1161/CIRCULATIONAHA.110.958405 |
P698 | PubMed publication ID | 21321151 |
P50 | author | Maria Loane | Q28484211 |
P2093 | author name string | H. Dolk | |
E. Garne | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 841-849 | |
P577 | publication date | 2011-02-14 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Congenital Heart Defects in Europe: Prevalence and Perinatal Mortality, 2000 to 2005 | |
P478 | volume | 123 |
Q59465776 | 3D printing in medicine of congenital heart diseases |
Q91899268 | A Study of Mortality in Cardiac Patients in a Pediatric Intensive Care Unit |
Q90390572 | A de novo splicing variant supports the candidacy of TLL1 in ASD pathogenesis |
Q42186727 | A mouse model of human congenital heart disease: high incidence of diverse cardiac anomalies and ventricular noncompaction produced by heterozygous Nkx2-5 homeodomain missense mutation |
Q34461709 | A prospective observational study of associated anomalies in Hirschsprung's disease |
Q36135123 | A systematic review of prenatal screening for congenital heart disease by fetal electrocardiography |
Q64982309 | Acute therapy of newborns with critical congenital heart disease. |
Q92949935 | Adolescents with congenital heart defects: a patient and parental perspective of genetic information and genetic risk |
Q36960490 | Ambient air pollution and traffic exposures and congenital heart defects in the San Joaquin Valley of California |
Q30838489 | Analysis of Craniocardiac Malformations in Xenopus using Optical Coherence Tomography. |
Q90319402 | Anatomy of the ventricular septal defect in congenital heart defects: a random association? |
Q36732829 | Assessing sociodemographic differences (or lack thereof) in prenatal diagnosis of congenital heart defects: a population-based study |
Q36459425 | Assisted reproductive techniques and the risk of anorectal malformations: a German case-control study |
Q51020875 | Association of TGFBR2 rs6785358 Polymorphism with Increased Risk of Congenital Ventricular Septal Defect in a Chinese Population. |
Q37470027 | Association of maternal chronic disease with risk of congenital heart disease in offspring |
Q40078233 | Association of maternal diseases during pregnancy with the risk of single ventricular septal defects in the offspring--a population-based case-control study |
Q46379193 | Birth outcomes of cases with conotruncal defects of heart - a population-based case-control study |
Q40078716 | Birth outcomes of cases with isolated atrial septal defect type II--a population-based case-control study |
Q40993972 | Birth prevalence of congenital heart disease: A cross-sectional observational study from North India |
Q34500979 | CRISPR/Cas9: An inexpensive, efficient loss of function tool to screen human disease genes in Xenopus. |
Q36131253 | Cardiopulmonary Bypass Down-Regulates NOD Signaling and Inflammatory Response in Children with Congenital Heart Disease |
Q35674245 | Characterization of SMAD3 Gene Variants for Possible Roles in Ventricular Septal Defects and Other Congenital Heart Diseases |
Q45181290 | Clinical and socioeconomic predictors of pregnancy termination for fetuses with congenital heart defects: a population-based evaluation |
Q45104477 | Clinical characteristics and outcome of incidental atrial septal openings in very low birth weight infants |
Q40488157 | Congenital Heart Disease in Premature Infants 25-32 Weeks' Gestational Age. |
Q34523686 | Congenital anomalies among live births in a polluted area. A ten-year retrospective study |
Q46812506 | Congenital heart defect case ascertainment by the Alberta Congenital Anomalies Surveillance System |
Q53665745 | Congenital heart defects in La Réunion Island: a 6-year survey within a EUROCAT-affiliated congenital anomalies registry. |
Q34279541 | Congenital heart disease and chromossomopathies detected by the karyotype |
Q38150590 | Congenital heart disease in 37,294 births in Tunisia: birth prevalence and mortality rate |
Q35925029 | Congenital heart operations performed in the first year of life: does geographic variation exist? |
Q57283690 | Copenhagen Baby Heart Study: a population study of newborns with prenatal inclusion |
Q35536567 | Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever |
Q24658554 | Declines in stillbirth and neonatal mortality rates in Europe between 2004 and 2010: results from the Euro-Peristat project |
Q92411351 | Defective coronary vessel organization and reduction of VEGF-A in mouse embryonic hearts with gestational mild hypoxia |
Q48398599 | Detailed transabdominal fetal anatomic scanning in the late first trimester versus the early second trimester of pregnancy |
Q57077325 | EUROCAT: an update on its functions and activities |
Q50667102 | Early pregnancy exposure to antihistamines and risk of congenital heart defects: results of two case-control studies. |
Q48609752 | Education and support needs of the older adult with congenital heart disease |
Q44713435 | Education in obstetrical ultrasound--an important factor for increasing the prenatal detection of congenital heart disease |
Q58127400 | Effect of Fetal Growth on 1-Year Mortality in Neonates With Critical Congenital Heart Disease |
Q37204539 | Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes |
Q39919059 | Elevated birth prevalence of conotruncal heart defects in a population with high consanguinity rate. |
Q34391295 | Epidemiology of Cardiovascular Malformations among Newborns in Monchegorsk (North-West Russia): a Register-Based Study |
Q37993144 | Fetal cardiac screening and variation in prenatal detection rates of congenital heart disease: why bother with screening at all? |
Q43931355 | Folic acid fortification and the birth prevalence of congenital heart defect cases in Alberta, Canada |
Q47627491 | Genealogical and molecular analysis of a family-based cohort of congenital heart disease patients from the São Miguel Island (Azores, Portugal). |
Q60487647 | High mortality due to congenital malformations in children aged < 1 year in French Guiana |
Q36103084 | Hyperglycemia impairs left-right axis formation and thereby disturbs heart morphogenesis in mouse embryos |
Q49270535 | Identification of novel genomic imbalances in Saudi patients with congenital heart disease. |
Q90682115 | Impact of congenital heart disease on siblings: A review |
Q38864049 | Impact of fetal alcohol exposure on body systems: A systematic review |
Q45947454 | Impact of introduction of 20-week ultrasound scan on prevalence and fetal and neonatal outcomes in cases of selected severe congenital heart defects in The Netherlands. |
Q46827899 | Impact of prenatal diagnosis on survival of newborns with four congenital heart defects: a prospective, population-based cohort study in France (the EPICARD Study). |
Q33691652 | Impact of preterm birth on infant mortality for newborns with congenital heart defects: The EPICARD population-based cohort study |
Q36074912 | Incidence of Congenital Heart Disease: The 9-Year Experience of the Guangdong Registry of Congenital Heart Disease, China |
Q34355317 | Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disorders |
Q55266754 | Intravenous morphine versus intravenous paracetamol after cardiac surgery in neonates and infants: a study protocol for a randomized controlled trial. |
Q55300844 | Involvement of persons with lived experience of a prenatal diagnosis of congenital heart defect: an explorative study to gain insights into perspectives on future research. |
Q89870051 | Iron-deficiency anaemia in children with congenital heart diseases at a teaching hospital in Ghana |
Q30421635 | Is MRI the preferred method for evaluating right ventricular size and function in patients with congenital heart disease?: MRI is the preferred method for evaluating right ventricular size and function in patients with congenital heart disease |
Q41264527 | Is the probability of prenatal diagnosis or termination of pregnancy different for fetuses with congenital anomalies conceived following assisted reproductive techniques? A population-based evaluation of fetuses with congenital heart defects |
Q44408265 | Isolated atrioventricular canal defects: birth outcomes and risk factors: a population-based Hungarian case-control study, 1980-1996. |
Q49555073 | JNK and NF-κB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure |
Q91352674 | Lack of access to paediatric cardiology services in the public health system in four major urban centres in Perú |
Q55058447 | Laterality defects in the national birth defects prevention study (1998-2007): birth prevalence and descriptive epidemiology. |
Q39135264 | Level, Causes and Risk Factors of Neonatal Mortality, in Jordan: Results of a National Prospective Study |
Q37076054 | Long-Term Survival of Individuals Born With Congenital Heart Disease: A Systematic Review and Meta-Analysis |
Q98632777 | MANAGEMENT OF CONGENITAL CARDIAC SURGERY DURING COVID-19 PANDEMIC |
Q89442201 | Magnetic Resonance Imaging of Shear Stress and Wall Thickness in Tissue-Engineered Vascular Grafts |
Q57077332 | Major congenital anomalies in babies born with Down syndrome: A EUROCAT population-based registry study |
Q102075495 | Maternal B-vitamin intake and B-vitamin supplementation during pregnancy in relation to neonatal congenital heart defects: a case-control study with propensity score matching |
Q92534788 | Maternal Exposure to Housing Renovation During Pregnancy and Risk of Offspring with Congenital Malformation: The Japan Environment and Children's Study |
Q61798663 | Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome |
Q36800874 | Maternal hypertension with nifedipine treatment associated with a higher risk for right-sided obstructive defects of the heart: a population-based case-control study |
Q45028129 | Measurement of nuchal translucency for prenatal screening of congenital heart defects: a population-based evaluation |
Q57091921 | Mechanism Sharing Between Genetic and Gestational Hypoxia-Induced Cardiac Anomalies |
Q41014050 | Mesodermal expression of Moz is necessary for cardiac septum development |
Q24804007 | Monitoring of IVF birth outcomes in Finland: a data quality study |
Q37889824 | More folic acid, the five questions: why, who, when, how much, and how. |
Q41292053 | Natural history of prenatal isolated muscular ventricular septal defects. |
Q89807094 | Neonatal Outcomes in Very Preterm Infants With Severe Congenital Heart Defects: An International Cohort Study |
Q101141379 | Next-Generation Sequencing in a Series of 80 Fetuses with Complex Cardiac Malformations and/or Heterotaxy |
Q39006195 | Noninvasive hemodynamic assessment, treatment outcome prediction and follow-up of aortic coarctation from MR imaging |
Q37639067 | Novel associations in disorders of sex development: findings from the I-DSD Registry |
Q48093262 | Outcome after prenatal and postnatal diagnosis of complex congenital heart defects and the influence of genetic anomalies |
Q92355870 | Oximetry and neonatal examination for the detection of critical congenital heart disease: a systematic review and meta-analysis |
Q58605465 | Parental attitudes and willingness to donate children's biospecimens for congenital heart disease research: a cross-sectional study in Shanghai, China |
Q33903395 | Parental risk factors and anorectal malformations: systematic review and meta-analysis |
Q96960106 | Perioperative care of the newborns with CHDs in the time of COVID-19 |
Q47564828 | Person-centred transition programme to empower adolescents with congenital heart disease in the transition to adulthood: a study protocol for a hybrid randomised controlled trial (STEPSTONES project). |
Q91899871 | Personalized Cardiovascular Regenerative Medicine: Targeting the Extreme Stages of Life |
Q92789251 | Phenotyping congenital anomalies in administrative hospital records |
Q41070812 | Postoperative Pericardial Adhesion Prevention Using Collagen Membrane in Pigs: A Pilot Study |
Q91792693 | Potential association of long noncoding RNA HA117 with tetralogy of Fallot |
Q35561842 | Predicting Outcomes Using the Heart Failure Survival Score in Adults with Moderate or Complex Congenital Heart Disease |
Q99596927 | Pregnancy and early post-natal outcomes of fetuses with functionally univentricular heart in a low-and-middle-income country |
Q34526554 | Prematurity, asphyxia and congenital malformations underrepresented among neonates in a tertiary pediatric hospital in Vietnam |
Q35674107 | Prenatal Alcohol Exposure and Congenital Heart Defects: A Meta-Analysis |
Q37550962 | Prenatal detection of congenital heart diseases: one-year survey performing a screening protocol in a single reference center in Brazil |
Q91591913 | Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study |
Q33586243 | Presence of plaque, gingivitis and caries in Sudanese children with congenital heart defects |
Q34035859 | Prevalence and factors associated with congenital malformations in tirana, Albania, during 2011-2013. |
Q35758646 | Prevalence of Congenital Heart Disease in Xinjiang Multi-Ethnic Region of China |
Q49112073 | Prevalence of congenital heart disease among Palestinian children born in the Gaza Strip |
Q45070803 | Prevalence of congenital heart disease at live birth: an accurate assessment by echocardiographic screening |
Q37224526 | Profile and risk factors for congenital heart defects: A study in a tertiary care hospital |
Q37560116 | Proportion of selected congenital heart defects attributable to recognized risk factors |
Q41905825 | Quality of Patient Information Websites About Congenital Heart Defects: Mixed-Methods Study of Perspectives Among Individuals With Experience of a Prenatal Diagnosis |
Q58562094 | Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease |
Q24200508 | Red cell transfusion management for patients undergoing cardiac surgery for congenital heart disease |
Q24201453 | Red cell transfusion management for patients undergoing cardiac surgery for congenital heart disease |
Q52337414 | Risk factors and methylenetetrahydrofolate reductase gene in congenital heart disease. |
Q95565560 | Risk factors for congenital heart defects in two populations residing in the same geographic area: a long-term population-based study, Southern Israel |
Q46404500 | Risk factors in the origin of congenital left-ventricular outflow-tract obstruction defects of the heart: a population-based case-control study |
Q90418690 | Risk of Clinically Relevant Pericardial Effusion After Pediatric Cardiac Surgery |
Q34632605 | Risk of cancer associated with cardiac catheterization procedures during childhood: a cohort study in France. |
Q55080400 | Risk of congenital heart disease in relatives of probands with conotruncal cardiac defects: an evaluation of 1,620 families. |
Q35997982 | Routine use of color Doppler in fetal heart scanning in a low-risk population |
Q40764468 | Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study |
Q89684989 | Severe congenital heart defects: incidence, causes and time trends of preoperative mortality in Norway |
Q35058476 | Sleep and its importance in adolescence and in common adolescent somatic and psychiatric conditions |
Q38610290 | Stillbirth and neonatal mortality in pregnancies complicated by major congenital anomalies: findings from a large European cohort |
Q47671876 | Systematic review and meta-analysis of the performance of second-trimester screening for prenatal detection of congenital heart defects |
Q35754694 | Temporal trends in survival among infants with critical congenital heart defects |
Q36531802 | The Application of an Anatomical Database for Fetal Congenital Heart Disease |
Q99552224 | The Baby Hearts Study - a case-control methodology with data linkage to evaluate risk and protective factors for congenital heart disease |
Q90674148 | The Outcome of Prenatally Diagnosed Isolated Fetal Ventricular Septal Defect |
Q39442897 | The changing epidemiology of Ebstein's anomaly and its relationship with maternal mental health conditions: a European registry-based study |
Q38016971 | The evolution of prenatal screening and diagnosis and its impact on an unselected population over an 18-year period |
Q36854388 | The impact of congenital heart diseases on the quality of life of patients and their families in Saudi Arabia. Biological, psychological, and social dimensions |
Q53412570 | The lived experience of parents whose children discharged to home after cardiac surgery for congenital heart disease. |
Q52674413 | The long non-coding RNA uc.4 influences cell differentiation through the TGF-beta signaling pathway. |
Q38222880 | The role of post-translational modifications in acute and chronic cardiovascular disease |
Q47868970 | Tissue-engineered vascular grafts for congenital cardiac disease: Clinical experience and current status |
Q50638249 | Toxic effects of polychlorinated biphenyls on cardiac development in zebrafish. |
Q92389731 | Transition program for adolescents with congenital heart disease in transition to adulthood: protocol for a mixed-method process evaluation study (the STEPSTONES project) |
Q35777487 | Transition to home after neonatal surgery for congenital heart disease |
Q48509176 | Translation and Testing of the Swedish Version of Iceland-Family Perceived Support Questionnaire With Parents of Children With Congenital Heart Defects |
Q54241203 | Trends in congenital anomalies in Europe from 1980 to 2012. |
Q47546248 | Wide variation in severe neonatal morbidity among very preterm infants in European regions. |
Search more.